Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Octreotide-induced hyperkalemia

A I Sargent1, C C Overton, R J Kuwik

  • 1Department of Pharmacy, Mercy Hospital of Pittsburgh, PA 15219.

Pharmacotherapy
|July 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Substantial reservoirs of molecular hydrogen in the debris disks around young stars.

Nature·2001
Same author

Supraglottic and subglottic airway injury due to deployment and rupture of an automobile airbag.

The American surgeon·1997
Same author

A rotating disk of gas and dust around a young counterpart to beta Pictoris.

Nature·1997
Same author

The use of a permanent dermal allograft in full-thickness burns of the hand and foot: a report of three cases.

The Journal of burn care & rehabilitation·1997
Same author

Circumstellar disks and the search for neighbouring planetary systems.

Nature·1996
Same author

Internal jugular vein and carotid artery anatomic relation as determined by ultrasonography.

Anesthesiology·1996
Same journal

Comment on "Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis".

Pharmacotherapy·2026
Same journal

Response to Comment on "Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis".

Pharmacotherapy·2026
Same journal

The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers.

Pharmacotherapy·2026
Same journal

Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.

Pharmacotherapy·2026
Same journal

Getting It Right the Second Time: How Can we Optimize First-Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?

Pharmacotherapy·2026
Same journal

Buprenorphine Initiation During Extracorporeal Membrane Oxygenation Decreases Sedative and Opioid Exposure: A Retrospective Matched Case-Control Study.

Pharmacotherapy·2026
See all related articles

Octreotide therapy can cause hyperkalemia (elevated serum potassium) in patients with normal renal function. Discontinuation of octreotide led to a decrease in potassium levels, and rechallenge confirmed the drug

Area of Science:

  • Endocrinology
  • Gastroenterology
  • Clinical Pharmacology

Background:

  • Pancreatic fistulas often require pharmacologic management.
  • Octreotide is a somatostatin analog used to manage various conditions, including pancreatic fistulas.

Observation:

  • A 68-year-old female patient developed hyperkalemia during octreotide treatment for a pancreatic fistula.
  • The patient had no renal impairment and was asymptomatic.
  • Hyperkalemia resolved upon octreotide discontinuation and recurred upon rechallenge.

Findings:

  • Octreotide administration was temporally associated with the development of hyperkalemia.
  • The patient's serum potassium levels normalized after octreotide was stopped.
  • Reintroduction of octreotide led to a reproducible increase in serum potassium.

Related Experiment Videos

Implications:

  • Clinicians should monitor serum potassium levels in patients receiving octreotide, even those with normal renal function.
  • Octreotide-induced hyperkalemia is a potential adverse effect that warrants consideration in patient management.
  • This case highlights a possible drug-induced electrolyte disturbance that may require therapeutic intervention or drug discontinuation.